PhRMA Statement On Prescription Medicines Spending
PhRMA Statement on Prescription Medicines Spending Washington, D.C. (November 11, 2009) -- Pharmaceutical Research and Manufacturers of America (PhRM...
PhRMA Statement on Prescription Medicines Spending Washington, D.C. (November 11, 2009) -- Pharmaceutical Research and Manufacturers of America (PhRM...
ProPublica | Olga Pierce | Posted 10.20.2009 | Politics
Four years ago, a group of lawmakers and aides crafted Medicare Part D, the prescription drug program for seniors that has produced billions of dollar...
AP | Posted 09.20.2009 | Business
WASHINGTON - The pharmaceutical industry's primary trade group spent nearly $6.2 million lobbying in the second quarter on health care reform provisio...
HuffingtonPost.com | Jason Linkins | Posted 09.20.2009 | Politics
This past weekend, the New York Times's Katharine Seelye took stock of the advertising battle that's been raging over health care reform, to the tune ...
John Marshall | Posted 09.14.2009 | Comedy
In an effort to pass a bipartisan bill with a Republican party that wouldn't give him a glass of water if his tie were on fire, President Obama plans to eliminate "health" and "care" from his health care reform plan.
Drew Westen | Posted 09.13.2009 | Politics
The American people did not vote for "bipartisan" solutions that split the difference between the failed ideology of the last eight years and the change the president and the super-majorities they elected in both houses of Congress promised.
Robert Reich | Posted 09.11.2009 | Politics
I'm a strong supporter of universal health insurance, and a fan of the Obama administration. But I'm appalled by the deal the White House has made with the pharmaceutical industry's lobbying arm to buy their support.
Merrill Goozner | Posted 09.11.2009 | Politics
Reformers were naïve if they thought the world had changed simply because there were new tenants in the majority offices on the Hill or in the White House.
Arianna Huffington | Posted 09.10.2009 | Politics
The White House may be willing to cave on drug price negotiations and having a public option. Giving us health care reform without those key ingredients is like serving a PBJ sandwich without the peanut butter or the jelly.
Posted 09.10.2009 | Politics
In yet another in a series of evolving statements and backtracks, an official with the country's major pharmaceutical lobby said on Monday that it nev...
Bryan Young | Posted 09.08.2009 | Politics
Bringing lobbyists from Big Pharma into the health care negotiations is anathema to the process and makes them feel like they deserve a place at that table.
James Love | Posted 09.06.2009 | Politics
The White House has abandoned any real effort to control costs in the pharma sector and Democrats have taken this hands-off approach as a green light to side with Big Pharma.
HuffingtonPost.com | Jason Linkins | Posted 09.03.2009 | Politics
In today's Los Angeles Times Tom Hamburger reports on the extent to which former Louisiana Congressman Billy Tauzin has managed to integrate himself, ...
James Love | Posted 08.31.2009 | Politics
The Eshoo/Barton amendment, which has the support of many newly pro-PhRMA democrats, will extend the period of monopolies for biologic medicines.
Sunil Chacko | Posted 07.24.2009 | World
The overflow crowd at the US-India Business Council's "Synergies Summit" emphasized how positively different the Council has become from even a dozen years ago.
HuffingtonPost.com | Sam Stein | Posted 04.24.2009 | Politics
A key industry official in the health care debate praised the Obama administration on Tuesday for taking an "us"-oriented approach when it came to rev...
HuffingtonPost.com | Sam Stein | Posted 11.11.2009 | Business